410 related articles for article (PubMed ID: 26034202)
1. Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy.
Jiang X; Deng KQ; Luo Y; Jiang DS; Gao L; Zhang XF; Zhang P; Zhao GN; Zhu X; Li H
Hypertension; 2015 Aug; 66(2):356-67. PubMed ID: 26034202
[TBL] [Abstract][Full Text] [Related]
2. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
[TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy.
Jiang DS; Liu Y; Zhou H; Zhang Y; Zhang XD; Zhang XF; Chen K; Gao L; Peng J; Gong H; Chen Y; Yang Q; Liu PP; Fan GC; Zou Y; Li H
Hypertension; 2014 Apr; 63(4):713-22. PubMed ID: 24396025
[TBL] [Abstract][Full Text] [Related]
4. Growth Arrest-Specific 6 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy.
Zhao YF; Xu DC; Zhu GF; Zhu MY; Tang K; Li WM; Xu YW
Hypertension; 2016 Jan; 67(1):118-29. PubMed ID: 26573712
[TBL] [Abstract][Full Text] [Related]
5. Novel role for caspase-activated DNase in the regulation of pathological cardiac hypertrophy.
Gao L; Huang K; Jiang DS; Liu X; Huang D; Li H; Zhang XD; Huang K
Hypertension; 2015 Apr; 65(4):871-81. PubMed ID: 25646292
[TBL] [Abstract][Full Text] [Related]
6. Regulator of G-Protein Signaling 10 Negatively Regulates Cardiac Remodeling by Blocking Mitogen-Activated Protein Kinase-Extracellular Signal-Regulated Protein Kinase 1/2 Signaling.
Miao R; Lu Y; Xing X; Li Y; Huang Z; Zhong H; Huang Y; Chen AF; Tang X; Li H; Cai J; Yuan H
Hypertension; 2016 Jan; 67(1):86-98. PubMed ID: 26573707
[TBL] [Abstract][Full Text] [Related]
7. C-C Motif Chemokine Receptor 9 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction.
Xu Z; Mei F; Liu H; Sun C; Zheng Z
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146447
[TBL] [Abstract][Full Text] [Related]
8. Stem cell antigen 1 protects against cardiac hypertrophy and fibrosis after pressure overload.
Zhou H; Bian ZY; Zong J; Deng W; Yan L; Shen DF; Guo H; Dai J; Yuan Y; Zhang R; Lin YF; Hu X; Li H; Tang QZ
Hypertension; 2012 Sep; 60(3):802-9. PubMed ID: 22851736
[TBL] [Abstract][Full Text] [Related]
9. Neuron-Specific Tumor Necrosis Factor Receptor-Associated Factor 3 Is a Central Regulator of Neuronal Death in Acute Ischemic Stroke.
Gong J; Li ZZ; Guo S; Zhang XJ; Zhang P; Zhao GN; Gao L; Zhang Y; Zheng A; Zhang XF; Xiang M; Li H
Hypertension; 2015 Sep; 66(3):604-16. PubMed ID: 26269654
[TBL] [Abstract][Full Text] [Related]
10. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
11. Caspase recruitment domain 6 protects against cardiac hypertrophy in response to pressure overload.
Li L; Chen W; Zhu Y; Wang X; Jiang DS; Huang F; Wang L; Xiang F; Qin W; Wang Q; Zhang R; Zhu X; Li H; Chen X
Hypertension; 2014 Jul; 64(1):94-102. PubMed ID: 24777975
[TBL] [Abstract][Full Text] [Related]
12. Critical Role of ADAMTS2 (A Disintegrin and Metalloproteinase With Thrombospondin Motifs 2) in Cardiac Hypertrophy Induced by Pressure Overload.
Wang X; Chen W; Zhang J; Khan A; Li L; Huang F; Qiu Z; Wang L; Chen X
Hypertension; 2017 Jun; 69(6):1060-1069. PubMed ID: 28373586
[TBL] [Abstract][Full Text] [Related]
13. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
[TBL] [Abstract][Full Text] [Related]
14. Regulator of G Protein Signaling 6 Facilities Cardiac Hypertrophy by Activating Apoptosis Signal-Regulating Kinase 1-P38/c-JUN N-Terminal Kinase 1/2 Signaling.
Huang Z; Shu J; Jiang W; Jiang M; Lu Y; Dai H; Xu N; Yuan H; Cai J
J Am Heart Assoc; 2018 Oct; 7(19):e009179. PubMed ID: 30371330
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV protects against the pathological cardiac hypertrophy in mice.
Liu ZH; Liu HB; Wang J
Biomed Pharmacother; 2018 Jan; 97():1468-1478. PubMed ID: 29793309
[TBL] [Abstract][Full Text] [Related]
16. Restoration of Circulating MFGE8 (Milk Fat Globule-EGF Factor 8) Attenuates Cardiac Hypertrophy Through Inhibition of Akt Pathway.
Deng KQ; Li J; She ZG; Gong J; Cheng WL; Gong FH; Zhu XY; Zhang Y; Wang Z; Li H
Hypertension; 2017 Oct; 70(4):770-779. PubMed ID: 28827473
[TBL] [Abstract][Full Text] [Related]
17. Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways.
Clemente CF; Xavier-Neto J; Dalla Costa AP; Consonni SR; Antunes JE; Rocco SA; Pereira MB; Judice CC; Strauss B; Joazeiro PP; Matos-Souza JR; Franchini KG
J Mol Cell Cardiol; 2012 Feb; 52(2):493-501. PubMed ID: 22056317
[TBL] [Abstract][Full Text] [Related]
18. Cardiac-Specific EPI64C Blunts Pressure Overload-Induced Cardiac Hypertrophy.
Zhu X; Fang J; Gong J; Guo JH; Zhao GN; Ji YX; Liu HY; Wei X; Li H
Hypertension; 2016 May; 67(5):866-77. PubMed ID: 27021007
[TBL] [Abstract][Full Text] [Related]
19. Activation of distinct signal transduction pathways in hypertrophied hearts by pressure and volume overload.
Miyamoto T; Takeishi Y; Takahashi H; Shishido T; Arimoto T; Tomoike H; Kubota I
Basic Res Cardiol; 2004 Sep; 99(5):328-37. PubMed ID: 15309410
[TBL] [Abstract][Full Text] [Related]
20. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
